128 related articles for article (PubMed ID: 34954767)
1. Identification of potential druggable targets of cell cycle with small-molecule inhibitors in oral squamous cell carcinoma.
Zhou X; Jin W; Chen Y; Zhu L; Mo A; Xie Q
Pharmacogenet Genomics; 2022 Jun; 32(4):125-137. PubMed ID: 34954767
[TBL] [Abstract][Full Text] [Related]
2. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
3. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
Zhang YY; Mao MH; Han ZX
Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
[TBL] [Abstract][Full Text] [Related]
4. Screening and identification of autophagy-related biomarkers for oral squamous cell carcinoma (OSCC) via integrated bioinformatics analysis.
Huang GZ; Lu ZY; Rao Y; Gao H; Lv XZ
J Cell Mol Med; 2021 May; 25(9):4444-4454. PubMed ID: 33837652
[TBL] [Abstract][Full Text] [Related]
5. Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.
Lin YC; Chen BS
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142321
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
7. CDK1 and CCNA2 play important roles in oral squamous cell carcinoma.
Zhang J; Di Y; Zhang B; Li T; Li D; Zhang H
Medicine (Baltimore); 2024 Apr; 103(16):e37831. PubMed ID: 38640322
[TBL] [Abstract][Full Text] [Related]
8. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
Tang Y; Xiao Y; Liao R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
[TBL] [Abstract][Full Text] [Related]
9. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.
Yang Z; Liang X; Fu Y; Liu Y; Zheng L; Liu F; Li T; Yin X; Qiao X; Xu X
EBioMedicine; 2019 Sep; 47():44-57. PubMed ID: 31409573
[TBL] [Abstract][Full Text] [Related]
10. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology and bioinformatics analysis on the underlying mechanisms of baicalein against oral squamous cell carcinoma.
Tang B; Dong Y
J Gene Med; 2023 Jun; 25(6):e3490. PubMed ID: 36843559
[TBL] [Abstract][Full Text] [Related]
12. IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma.
Wang X; Xu H; Zhou Z; Guo S; Chen R
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35129592
[TBL] [Abstract][Full Text] [Related]
13. Identification of a six-gene prognostic signature for oral squamous cell carcinoma.
Wang J; Wang Y; Kong F; Han R; Song W; Chen D; Bu L; Wang S; Yue J; Ma L
J Cell Physiol; 2020 Mar; 235(3):3056-3068. PubMed ID: 31538341
[TBL] [Abstract][Full Text] [Related]
14. Potential role of differentially expressed lncRNAs in the pathogenesis of oral squamous cell carcinoma.
Zhang S; Tian L; Ma P; Sun Q; Zhang K; GuanchaoWang ; Liu H; Xu B
Arch Oral Biol; 2015 Oct; 60(10):1581-7. PubMed ID: 26276270
[TBL] [Abstract][Full Text] [Related]
15. [MicroRNA model that can predict the prognosis of oral squamous cell carcinoma based on bioinformatics analysis].
Zhao G; Li CX; Guo C; Zhu H
Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Dec; 38(6):622-627. PubMed ID: 33377337
[TBL] [Abstract][Full Text] [Related]
16. Identification of Candidate Target Genes and Immune Cells in Oral Squamous Cell Carcinoma.
Xie P; Wu S; Guo L; Ren J; Cai K; Zhou M; Liu W; Yang S
Comput Math Methods Med; 2021; 2021():5802110. PubMed ID: 35003322
[TBL] [Abstract][Full Text] [Related]
17. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C
Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734
[TBL] [Abstract][Full Text] [Related]
18. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
Xu Z; Jiang P; He S
Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
[TBL] [Abstract][Full Text] [Related]
19. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
[TBL] [Abstract][Full Text] [Related]
20. Prognostic model based on telomere-related genes predicts the risk of oral squamous cell carcinoma.
Yue K; Yao X
BMC Oral Health; 2023 Jul; 23(1):484. PubMed ID: 37452322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
